Early on a beautiful spring morning in the nation’s capital, a group of Georgetown University undergraduates gathered on the corner of First Street and Constitution Avenue, far from their textbooks and thoughts of their looming final exams. Their unusual study break? A day of meetings with congressional offices to advocate against cuts to critical U.S. government funding for global health.
For years, little was known of the typhoid burden in Africa, even though outbreaks of multi-drug resistant typhoid is becoming increasingly common. This lack of information spurred the Bill and Melinda Gates Foundation to fund the Typhoid Fever Surveillance in Africa Program (TSAP) through the International Vaccine Institute, a first-of-its-kind study established to shed light on true extent of the typhoid burden and multi-drug resistance distribution on the continent. The results from the TSAP, recently published in the Lancet Global Health, represent the most comprehensive and rigorous analysis of typhoid in Africa and could change our understanding of the disease burden across the continent.

Vaccines are healthcare’s first line of defense. From polio to pertussis, rubella to rotavirus, vaccination has saved more lives than any other medical advance in recent history.

Global health research and development has a multiplier effect. It not only saves and improves lives, but also creates cost savings, drives economic growth and enhances global security.

Pages